Pro
US-based private equity firm TPG and Swiss healthcare investor HBM Partners have changed their plans to monetize their bets on an Indian company but will still beat the exit benchmarks that alternative investment firms typically target in the South Asian nation. TPG and HBM will sell part of their stakes in ......